ID   ERBB2_RAT               Reviewed;        1257 AA.
AC   P06494; Q6P732;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 3.
DT   02-OCT-2024, entry version 217.
DE   RecName: Full=Receptor tyrosine-protein kinase erbB-2;
DE            EC=2.7.10.1;
DE   AltName: Full=Epidermal growth factor receptor-related protein;
DE   AltName: Full=Proto-oncogene Neu;
DE   AltName: Full=Proto-oncogene c-ErbB-2;
DE   AltName: Full=p185erbB2;
DE   AltName: Full=p185neu;
DE   AltName: CD_antigen=CD340;
DE   Flags: Precursor;
GN   Name=Erbb2; Synonyms=Neu;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Neuroblastoma;
RX   PubMed=3945311; DOI=10.1038/319226a0;
RA   Bargmann C.I., Hung M.-C., Weinberg R.A.;
RT   "The neu oncogene encodes an epidermal growth factor receptor-related
RT   protein.";
RL   Nature 319:226-230(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 634-699.
RX   PubMed=1682063; DOI=10.1093/carcin/12.10.1975;
RA   Masui T., Mann A.M., Macatee T.L., Garland E.M., Okamura T., Smith R.A.,
RA   Cohen S.M.;
RT   "Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals
RT   no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-
RT   hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or
RT   N-methyl-N-nitrosourea.";
RL   Carcinogenesis 12:1975-1978(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 852-905.
RC   TISSUE=Sciatic nerve;
RX   PubMed=2025425; DOI=10.1016/0896-6273(91)90167-x;
RA   Lai C., Lemke G.;
RT   "An extended family of protein-tyrosine kinase genes differentially
RT   expressed in the vertebrate nervous system.";
RL   Neuron 6:691-704(1991).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=7945309; DOI=10.1006/bbrc.1994.2368;
RA   Xie Y., Hung M.C.;
RT   "Nuclear localization of p185neu tyrosine kinase and its association with
RT   transcriptional transactivation.";
RL   Biochem. Biophys. Res. Commun. 203:1589-1598(1994).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1056; SER-1080 AND SER-1085,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   STRUCTURE BY NMR OF 650-668.
RX   PubMed=1346763; DOI=10.1002/j.1460-2075.1992.tb05025.x;
RA   Gullick W.J., Bottomley A.C., Lofts F.J., Doak D.G., Mulvey D., Newman R.,
RA   Crumpton M.J., Sternberg M.J.E., Campbell I.D.;
RT   "Three dimensional structure of the transmembrane region of the proto-
RT   oncogenic and oncogenic forms of the neu protein.";
RL   EMBO J. 11:43-48(1992).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 23-631 IN COMPLEX WITH THE
RP   ANTIBODY HERCEPTIN, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-68; ASN-188
RP   AND ASN-260.
RX   PubMed=12610629; DOI=10.1038/nature01392;
RA   Cho H.-S., Mason K., Ramyar K.X., Stanley A.M., Gabelli S.B.,
RA   Denney D.W. Jr., Leahy D.J.;
RT   "Structure of the extracellular region of HER2 alone and in complex with
RT   the Herceptin Fab.";
RL   Nature 421:756-760(2003).
CC   -!- FUNCTION: Protein tyrosine kinase that is part of several cell surface
CC       receptor complexes, but that apparently needs a coreceptor for ligand
CC       binding. Essential component of a neuregulin-receptor complex, although
CC       neuregulins do not interact with it alone. GP30 is a potential ligand
CC       for this receptor. Regulates outgrowth and stabilization of peripheral
CC       microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1
CC       signaling pathway elicits the phosphorylation and thus the inhibition
CC       of GSK3B at cell membrane. This prevents the phosphorylation of APC and
CC       CLASP2, allowing its association with the cell membrane. In turn,
CC       membrane-bound APC allows the localization of MACF1 to the cell
CC       membrane, which is required for microtubule capture and stabilization
CC       (By similarity). Interacts (preferentially with the tyrosine
CC       phosphorylated form) with CPNE3; this interaction occurs at the cell
CC       membrane and is increased in a growth factor heregulin-dependent manner
CC       (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P04626}.
CC   -!- FUNCTION: In the nucleus is involved in transcriptional regulation.
CC       Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter
CC       and activates its transcription. Implicated in transcriptional
CC       activation of CDKN1A; the function involves STAT3 and SRC. Involved in
CC       the transcription of rRNA genes by RNA Pol I and enhances protein
CC       synthesis and cell growth (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Homodimer. Heterodimer with EGFR, ERBB3 and ERBB4. Part of a
CC       complex with EGFR and either PIK3C2A or PIK3C2B. May interact with
CC       PIK3C2B when phosphorylated on Tyr-1198. Interacts with PRKCABP and
CC       PLXNB1. Interacts (when phosphorylated on Tyr-1250) with MEMO1.
CC       Interacts with MUC1. Interacts (when phosphorylated on Tyr-1141) with
CC       GRB7 (via SH2 domain). Interacts (when phosphorylated on Tyr-1250) with
CC       ERBIN Interacts with SRC, KPNB1, RANBP2, EEA1, CRM1, CLTC, PTK6,
CC       RPA194, MYOC and ACTB. Interacts with HSP90AA1 and HSP90AB1; the
CC       interaction suppresses ERBB2 kinase activity (By similarity). Interacts
CC       with SORL1; this interaction regulates ERBB2 subcellular distribution
CC       by promoting its recycling after internalization from endosomes back to
CC       the plasma membrane, hence stimulates ERBB2-mediated signaling (By
CC       similarity). Interacts with SH3BGRL (By similarity). Interacts with
CC       ROR1 (By similarity). {ECO:0000250|UniProtKB:P04626,
CC       ECO:0000250|UniProtKB:P70424}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P04626};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P04626}.
CC       Cell projection, ruffle membrane {ECO:0000250|UniProtKB:P04626};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P04626}.
CC       Early endosome {ECO:0000250|UniProtKB:P04626}. Cytoplasm, perinuclear
CC       region {ECO:0000250|UniProtKB:P04626}. Nucleus
CC       {ECO:0000250|UniProtKB:P04626}. Note=Translocation to the nucleus
CC       requires endocytosis, probably endosomal sorting and is mediated by
CC       importin beta-1/KPNB1. Also detected in endosome-to-TGN retrograde
CC       vesicles. Internalized from the cell membrane in response to EGF
CC       stimulation. {ECO:0000250|UniProtKB:P04626}.
CC   -!- PTM: Autophosphorylated. Autophosphorylation occurs in trans, i.e. one
CC       subunit of the dimeric receptor phosphorylates tyrosine residues on the
CC       other subunit. Ligand-binding increases phosphorylation on tyrosine
CC       residues. Signaling via SEMA4C promotes phosphorylation at Tyr-1250.
CC       Dephosphorylated by PTPN12. {ECO:0000250|UniProtKB:P04626}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. EGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH61863.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA27059.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03362; CAA27059.1; ALT_INIT; mRNA.
DR   EMBL; BC061863; AAH61863.1; ALT_INIT; mRNA.
DR   PIR; A24562; TVRTNU.
DR   PDB; 1IIJ; NMR; -; A=647-681.
DR   PDB; 1N8Y; X-ray; 2.40 A; C=23-631.
DR   PDBsum; 1IIJ; -.
DR   PDBsum; 1N8Y; -.
DR   AlphaFoldDB; P06494; -.
DR   SMR; P06494; -.
DR   STRING; 10116.ENSRNOP00000040591; -.
DR   BindingDB; P06494; -.
DR   ChEMBL; CHEMBL3848; -.
DR   GlyCosmos; P06494; 6 sites, No reported glycans.
DR   GlyGen; P06494; 6 sites.
DR   iPTMnet; P06494; -.
DR   PhosphoSitePlus; P06494; -.
DR   PaxDb; 10116-ENSRNOP00000040591; -.
DR   UCSC; RGD:2561; rat.
DR   AGR; RGD:2561; -.
DR   RGD; 2561; Erbb2.
DR   eggNOG; KOG1025; Eukaryota.
DR   InParanoid; P06494; -.
DR   PhylomeDB; P06494; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-1227986; Signaling by ERBB2.
DR   Reactome; R-RNO-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1306955; GRB7 events in ERBB2 signaling.
DR   Reactome; R-RNO-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-RNO-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-RNO-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-RNO-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6785631; ERBB2 Regulates Cell Motility.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-8847993; ERBB2 Activates PTK6 Signaling.
DR   Reactome; R-RNO-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-RNO-9652282; Drug-mediated inhibition of ERBB2 signaling.
DR   EvolutionaryTrace; P06494; -.
DR   PRO; PR:P06494; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0010008; C:endosome membrane; ISO:RGD.
DR   GO; GO:0038143; C:ERBB3:ERBB2 complex; ISO:RGD.
DR   GO; GO:0043219; C:lateral loop; IDA:RGD.
DR   GO; GO:0005902; C:microvillus; IDA:RGD.
DR   GO; GO:0043209; C:myelin sheath; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0002116; C:semaphorin receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015026; F:coreceptor activity; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0043125; F:ErbB-3 class receptor binding; ISO:RGD.
DR   GO; GO:0051879; F:Hsp90 protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0001042; F:RNA polymerase I core binding; ISS:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0038134; P:ERBB2-EGFR signaling pathway; ISO:RGD.
DR   GO; GO:0038133; P:ERBB2-ERBB3 signaling pathway; ISO:RGD.
DR   GO; GO:0038135; P:ERBB2-ERBB4 signaling pathway; IDA:MGI.
DR   GO; GO:0044849; P:estrous cycle; IMP:RGD.
DR   GO; GO:0010001; P:glial cell differentiation; IGI:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0033080; P:immature T cell proliferation in thymus; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0060056; P:mammary gland involution; IEP:RGD.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISO:RGD.
DR   GO; GO:0042552; P:myelination; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0033088; P:negative regulation of immature T cell proliferation in thymus; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; IBA:GO_Central.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0099645; P:neurotransmitter receptor localization to postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0007422; P:peripheral nervous system development; IMP:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:RGD.
DR   GO; GO:1905710; P:positive regulation of membrane permeability; IMP:RGD.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IMP:RGD.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; ISO:RGD.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; ISS:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; TAS:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; TAS:RGD.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0032886; P:regulation of microtubule-based process; ISS:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; IDA:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0033280; P:response to vitamin D; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0014044; P:Schwann cell development; ISO:RGD.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   GO; GO:0048485; P:sympathetic nervous system development; IMP:RGD.
DR   GO; GO:0043586; P:tongue development; IEP:RGD.
DR   GO; GO:0042060; P:wound healing; ISO:RGD.
DR   CDD; cd00064; FU; 3.
DR   CDD; cd05109; PTKc_HER2; 1.
DR   CDD; cd12094; TM_ErbB2; 1.
DR   Gene3D; 1.20.5.100; Cytochrome c1, transmembrane anchor, C-terminal; 1.
DR   Gene3D; 4.10.1140.10; membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor like domain; 1.
DR   Gene3D; 3.80.20.20; Receptor L-domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   IDEAL; IID50066; -.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR049328; TM_ErbB1.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   PANTHER; PTHR24416:SF137; RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   Pfam; PF21314; TM_ErbB1; 1.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 4.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 2.
DR   SUPFAM; SSF52058; L domain-like; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; ATP-binding; Cell membrane; Cell projection;
KW   Cytoplasm; Disulfide bond; DNA-binding; Endosome; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Receptor; Reference proteome; Signal; Transcription;
KW   Transcription regulation; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..1257
FT                   /note="Receptor tyrosine-protein kinase erbB-2"
FT                   /id="PRO_0000016671"
FT   TOPO_DOM        23..654
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        655..677
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        678..1257
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          722..989
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          678..691
FT                   /note="Required for interaction with KPNB1 and EEA1"
FT                   /evidence="ECO:0000250"
FT   REGION          1029..1181
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1197..1199
FT                   /note="Interaction with PIK3C2B"
FT                   /evidence="ECO:0000250"
FT   REGION          1200..1257
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           678..691
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        1222..1244
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        847
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         728..736
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         755
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         879
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   MOD_RES         1056
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1080
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1085
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   MOD_RES         1114
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   MOD_RES         1141
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   MOD_RES         1168
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   MOD_RES         1198
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   MOD_RES         1250
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   CARBOHYD        68
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   CARBOHYD        260
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12610629,
FT                   ECO:0007744|PDB:1N8Y"
FT   CARBOHYD        532
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        573
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        631
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        26..53
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        163..193
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        196..205
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        200..213
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        221..228
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        225..236
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        237..245
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        241..253
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        256..265
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        269..296
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        300..312
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        316..332
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        335..339
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        343..368
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        476..506
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        513..522
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        517..530
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        533..542
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        546..562
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        565..578
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        569..586
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        589..598
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        602..625
FT                   /evidence="ECO:0007744|PDB:1N8Y"
FT   DISULFID        628..636
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   DISULFID        632..644
FT                   /evidence="ECO:0000250|UniProtKB:P04626"
FT   VARIANT         661
FT                   /note="V -> E (in oncogenic NEU)"
FT   CONFLICT        145
FT                   /note="S -> G (in Ref. 2; AAH61863)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        505..509
FT                   /note="LCVSS -> CGLE (in Ref. 2; AAH61863)"
FT                   /evidence="ECO:0000305"
FT   STRAND          25..27
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           39..50
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          54..63
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           72..74
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          84..88
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   TURN            109..111
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          112..117
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          153..158
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           170..173
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           176..178
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          201..203
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          205..209
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          228..232
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           233..235
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          245..249
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          252..261
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          264..268
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          295..299
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          310..315
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          320..324
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          330..334
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           349..351
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   TURN            359..361
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           362..365
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          369..377
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           379..383
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   TURN            386..389
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           395..401
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          406..409
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          411..414
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           424..426
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   TURN            439..441
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          442..448
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          464..470
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           483..486
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          494..499
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   TURN            507..510
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           518..520
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          522..526
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          530..538
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          541..544
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          547..553
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          558..561
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          573..575
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          577..582
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           583..585
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          586..594
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          597..601
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          604..606
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          615..619
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   STRAND          623..627
FT                   /evidence="ECO:0007829|PDB:1N8Y"
FT   HELIX           650..669
FT                   /evidence="ECO:0007829|PDB:1IIJ"
FT   HELIX           670..674
FT                   /evidence="ECO:0007829|PDB:1IIJ"
FT   HELIX           675..679
FT                   /evidence="ECO:0007829|PDB:1IIJ"
SQ   SEQUENCE   1257 AA;  138832 MW;  6129264583011402 CRC64;
     MELAAWCRWG FLLALLPPGI AGTQVCTGTD MKLRLPASPE THLDMLRHLY QGCQVVQGNL
     ELTYVPANAS LSFLQDIQEV QGYMLIAHNQ VKRVPLQRLR IVRGTQLFED KYALAVLDNR
     DPQDNVAAST PGRTPEGLRE LQLRSLTEIL KGGVLIRGNP QLCYQDMVLW KDVFRKNNQL
     APVDIDTNRS RACPPCAPAC KDNHCWGESP EDCQILTGTI CTSGCARCKG RLPTDCCHEQ
     CAAGCTGPKH SDCLACLHFN HSGICELHCP ALVTYNTDTF ESMHNPEGRY TFGASCVTTC
     PYNYLSTEVG SCTLVCPPNN QEVTAEDGTQ RCEKCSKPCA RVCYGLGMEH LRGARAITSD
     NVQEFDGCKK IFGSLAFLPE SFDGDPSSGI APLRPEQLQV FETLEEITGY LYISAWPDSL
     RDLSVFQNLR IIRGRILHDG AYSLTLQGLG IHSLGLRSLR ELGSGLALIH RNAHLCFVHT
     VPWDQLFRNP HQALLHSGNR PEEDLCVSSG LVCNSLCAHG HCWGPGPTQC VNCSHFLRGQ
     ECVEECRVWK GLPREYVSDK RCLPCHPECQ PQNSSETCFG SEADQCAACA HYKDSSSCVA
     RCPSGVKPDL SYMPIWKYPD EEGICQPCPI NCTHSCVDLD ERGCPAEQRA SPVTFIIATV
     VGVLLFLILV VVVGILIKRR RQKIRKYTMR RLLQETELVE PLTPSGAMPN QAQMRILKET
     ELRKVKVLGS GAFGTVYKGI WIPDGENVKI PVAIKVLREN TSPKANKEIL DEAYVMAGVG
     SPYVSRLLGI CLTSTVQLVT QLMPYGCLLD HVREHRGRLG SQDLLNWCVQ IAKGMSYLED
     VRLVHRDLAA RNVLVKSPNH VKITDFGLAR LLDIDETEYH ADGGKVPIKW MALESILRRR
     FTHQSDVWSY GVTVWELMTF GAKPYDGIPA REIPDLLEKG ERLPQPPICT IDVYMIMVKC
     WMIDSECRPR FRELVSEFSR MARDPQRFVV IQNEDLGPSS PMDSTFYRSL LEDDDMGDLV
     DAEEYLVPQQ GFFSPDPTPG TGSTAHRRHR SSSTRSGGGE LTLGLEPSEE GPPRSPLAPS
     EGAGSDVFDG DLAMGVTKGL QSLSPHDLSP LQRYSEDPTL PLPPETDGYV APLACSPQPE
     YVNQSEVQPQ PPLTPEGPLP PVRPAGATLE RPKTLSPGKN GVVKDVFAFG GAVENPEYLV
     PREGTASPPH PSPAFSPAFD NLYYWDQNSS EQGPPPSNFE GTPTAENPEY LGLDVPV
//
